Integra LifeSciences IART Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's operating lease liabilities (total)?
- Integra LifeSciences (IART) reported operating lease liabilities (total) of $174.05M in Q1 2026.
- How has Integra LifeSciences's operating lease liabilities (total) changed year-over-year?
- Integra LifeSciences's operating lease liabilities (total) decreased by 0.9% year-over-year, from $175.65M to $174.05M.
- What is the long-term trend for Integra LifeSciences's operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Integra LifeSciences's operating lease liabilities (total) has grown at a 11.9% compound annual growth rate (CAGR), from $100.94M to $177.08M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.